Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

RADIANCE II US FDA IDE pivotal trial evaluating the Paradise Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant reduction in daytime ambulatory systolic blood pressure between treatment and a sham procedure measured at two months

News | Hypertension

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise System for the Treatment of Hypertension

July 29, 2022 — ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings ...

July 29, 2022

a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, used experimental models to discover that a natural product found in plants including safflower holds promise for treating a pair of hereditary sudden cardiac death syndromes

News | Embolization devices

Instylla Announces Positive Results From Preclinical Studies of Embrace Hydrogel Embolic System in Hemorrhage Models

July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

July 28, 2022

News | Sudden Cardiac Arrest

Main Line Health, Mayo researchers find natural product may prevent sudden cardiac death from rare inherited syndromes

July 28, 2022 — In 2020, a team of cardiovascular experts from the Lankenau Institute for Medical Research (LIMR), part ...

July 28, 2022

The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at Montefiore Health System in the Bronx.

News | Heart Failure

World’s First HIV-Positive to HIV-Positive Heart Transplant Performed at Montefiore Health System

July 27, 2022 — The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at Monte ...

July 27, 2022

Dr Aamir Hameed, Lecturer in the Department of Anatomy and Regenerative Medicine and a Principal Investigator with the Tissue Engineering Research Group at RCSI University of Medicine and Health Sciences

News | Heart Failure

New Heart Model to Help Treat Patients with Heart Failure

July 27, 2022 — Researchers from RCSI University of Medicine and Health Sciences have developed a new lab-based model of ...

July 27, 2022

Trial was negatively impacted by the COVID-19 pandemic and did not meet the primary endpoint

News | Pharmaceuticals

dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal

July 25, 2022 DalCor Pharmaceuticals announced the results of the dal-GenE Phase 3 cardiovascular precision medicine ...

July 25, 2022

that Dhanunjaya DJ Lakkireddy, MD, Medical Director for the Kansas City Heart Rhythm Institute, will initiate a research protocol analyzing the signals acquired by the PURE EP System during Radiofrequency (RF) ablation

News | Cardiovascular Clinical Studies

BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

July 22, 2022 — BioSig Technologies, Inc. a medical technology company advancing electrophysiology workflow by ...

July 22, 2022

Study intends to demonstrate that ultrasound allows for precise deployment and positive positioning of the MANTA vascular closure device

News | Cardiovascular Ultrasound

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first patient ...

July 20, 2022

Heart failure development program to focus on Short Term DSR with DSR 2.0

News | Heart Failure

Sequana Medical Completes Enrollment in Phase 2a SAHARA I DSR Study

July 20, 2022 — Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease and hea ...

July 20, 2022

The Cardiovascular AI Initiative, to be funded by NewYork-Presbyterian, was launched this summer in a virtual meeting featuring approximately 40 representatives from the institutions.

News | Artificial Intelligence

Collaboration Will Advance Cardiac Health Through AI

July 19, 2022 — Employing artificial intelligence to help improve outcomes for people with cardiovascular disease is the ...

July 19, 2022

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark submission for its MAGiC catheter.

News | Catheter

Stereotaxis Announces CE Mark Submission for Robotically Navigated Magic Ablation Catheter

July 18, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

July 19, 2022

News | Cardiovascular Clinical Studies

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure

July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products ...

July 19, 2022

MMRI Scientist Dr. Nathan Tucker co-authors groundbreaking study with team from The Broad Institute of MIT and Harvard, Bayer AG

News | Cardiovascular Clinical Studies

Molecular Heart Mapping and Cripsr Technology Create New Possibilities for Health Science

July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details ...

July 15, 2022

This model heart ventricle, made with real living heart cells, beats strongly enough to pump fluid inside a tube. It can be used to study heart disease and test out potential therapies, without the need for invasive surgery.

News | Artificial Heart

Reverse Engineering the Heart: University of Toronto Engineering Team Creates Bioartificial Left Ventricle

July 14, 2022 — University of Toronto Engineering researchers have grown a small-scale model of a human left heart ...

July 14, 2022

The authors analyzed data about 8,224 children who received cardiac transplants from January 1994 through September 2019. The data came from the Scientific Registry of Transplant Recipients (SRTR), a national database of all organ transplants in the United States. The researchers adjusted their analyses for factors including age, sex, cognitive difficulties, insurance status, transplant year and the reason for heart transplant.

News | Pediatric Cardiology

Study Finds Risk Disparity for Black Children Who Have Stroke After Heart Transplant

July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as ...

July 13, 2022